<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-041804</identifier>
<setSpec>0213-9111</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Use of analgesics and aspirin in a Spanish multicenter study</dc:title>
<dc:description xml:lang="en">Objective: To evaluate the use of acetaminophen (paracetamol), aspirin and dipyrone (metamizol) in a multicenter study. Patients and method: We analyzed the controls of a hospital-based case-control study (n = 1029) of bladder cancer using a matrix of drugs and active principles. The admission diagnosis of the study controls was not associated with chronic analgesic use. A logistic regression model was used. Results: Eight percent of the controls were regular users of aspirin, 5% regularly used acetaminophen and 2% regularly used dipyrone. Aspirin was more frequently used by subjects with at least secondary education (OR = 2.0; 95% CI, 1.52-2.93). Women more frequently used acetaminophen (OR = 1.91; 95% CI, 1.30-2.80) and dipyrone (OR = 2.80; 95% CI, 1.49-4.47). Subjects under 65 years old more frequently used dipyrone. Conclusion: Chronic use of aspirin and acetaminophen is lower than that reported in North America or northern Europe and is similar to that seen in southern Europe. Differences in the pattern of analgesic use were found among sociodemographic population groups</dc:description>
<dc:creator>Tardón, Adonina</dc:creator>
<dc:creator>Silverman, Debra</dc:creator>
<dc:creator>García-Closas, Reina</dc:creator>
<dc:creator>Fortuny, Joan</dc:creator>
<dc:creator>Carrato, Alfredo</dc:creator>
<dc:creator>Rothman, Nat</dc:creator>
<dc:creator>Serra, Consol</dc:creator>
<dc:creator>Kogevinas, Manolis</dc:creator>
<dc:creator>Dosemeci, Mustafa</dc:creator>
<dc:creator>Malats, Núria</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo: Evaluar el consumo de paracetamol, metamizol y ácido acetilsalicílico (AAS) en un estudio multicéntrico. Pacientes y método: Se analizaron los controles de un estudio de casos y controles hospitalarios (n = 1.029) sobre cáncer vesical mediante la aplicación de una matriz de medicamentos y principios activos. El motivo de ingreso de los controles no se asociaba con el uso crónico de analgésicos. Se utilizó un modelo de regresión logística. Resultados: El uso crónico de AAS fue del 8%, el de paracetamol, del 5% y el de metamizol, del 2%. El AAS fue más usado por personas con educación secundaria o superior (odds ratio [OR] = 2,0, intervalo de confianza [IC] del 95%, 1,52-2,93). Las mujeres usaron más paracetamol (OR = 1,91; IC del 95%, 1,30-2,80) y metamizol (OR = 2,80; IC del 95%, 1,49-4,47). Los menores de 65 años usaron más metamizol. Conclusión: El uso crónico de AAS y paracetamol es bajo comparado con el de Estados Unidos o el norte de Europa, aunque es parecido al del sur de Europa. Hay diferencias en el uso de analgésicos en función de las variables sociodemográficas</dc:description>
<dc:source>Gac Sanit;19(4): 316-320, jul. 2005.</dc:source>
<dc:identifier>ibc-041804</dc:identifier>
<dc:title xml:lang="es">Uso de analgésicos y ácido acetilsalicílico en un estudio multicéntrico en España</dc:title>
<dc:subject>^d27951^s22000</dc:subject>
<dc:subject>^d28021^s22073</dc:subject>
<dc:subject>^d32371^s22000</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d1774^s22057</dc:subject>
<dc:subject>^d714^s22000</dc:subject>
<dc:subject>^d28021^s22000</dc:subject>
<dc:subject>^d29640</dc:subject>
<dc:subject>^d24772</dc:subject>
<dc:subject>^d714^s22073</dc:subject>
<dc:subject>^d24551</dc:subject>
<dc:subject>^d22780</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d86^s22073</dc:subject>
<dc:subject>^d12530</dc:subject>
<dc:subject>^d13344</dc:subject>
<dc:subject>^d27938^s22073</dc:subject>
<dc:subject>^d32371^s22073</dc:subject>
<dc:subject>^d13411</dc:subject>
<dc:subject>^d86^s22000</dc:subject>
<dc:subject>^d27938^s22000</dc:subject>
<dc:subject>^d27951^s22073</dc:subject>
<dc:subject>^d14384</dc:subject>
<dc:type>article</dc:type>
<dc:date>200507</dc:date>
</metadata>
</record>
</ibecs-document>
